Yahoo Finance

  • What Biden Admin's new EV tax credit means for automakers

    The Biden Administration has officially finalized its tax credit rules for electric vehicles (EVs). One of the provisions outlined in the new rules is a restriction on sourcing critical minerals used in EV batteries from "foreign entities of concern," meaning countries like China. Yahoo Finance's Pras Subramanian sheds light on the implications of this rule for automakers moving forward. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance. This post was written by Angel Smith

  • What happens if Warner Bros. Discovery loses its NBA rights?

    Warner Bros. Discovery (WBD) is set to report earnings on Thursday, May 9, as the broadcaster engages in a tug-of-war with Comcast's NBCUniversal (CMCSA) over the media rights for the NBA. NBCUniversal is reportedly eyeing a bid of $2.5 billion, more than double WBD's current annual spend of $1.2 billion for NBA media rights. Yahoo Finance Senior Reporter Alexandra Canal highlights the detrimental consequences if Warner Bros. Discovery fails to secure the streaming rights for the next basketball season, as analysts project a loss of $270 million in annual ad revenue. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Melanie Riehl

  • The two ways Amgen's new weight-loss drug can stand out

    Pharmaceutical stock Amgen (AMGN) is rising following early positive results from the development of its new GLP-1 weight-loss drug, MariTide. Yahoo Finance Senior Health Reporter Anjalee Khemlani breaks down two ways MariTide could stand out among other obesity drugs, like Novo Nordisk's (NVO) Wegovy and Ozempic and Eli Lilly's (LLY) Zepbound and Mounjaro. Khemlani points to Amgen's claim that MariTide could be a monthly injection, giving it a significant leg up against drugs that require more frequent doses, like Ozempic. However, more data is needed before a final conclusion is made, and as phase three trials approach, all eyes are on whether the drug can successfully stand up to the claims. Additionally, pricing remains a major focus in the GLP-1 drug class, which Khemlani stresses will be a key factor in whether Amgen can successfully compete among some of the strongest market leaders. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Melanie Riehl

  • Apple: Three catalysts that can contribute to growth

    While Apple (AAPL) may have delivered a somewhat muted second-quarter performance, the tech giant still has several potential catalysts in its arsenal that could reignite its growth trajectory and propel the company to new heights. Yahoo Finance's Ines Ferre breaks down the details. For more expert insight and the latest market action, click here to watch this full episode of Catalysts. This post was written by Angel Smith

  • Weight-loss drug competition heats up. Is Wegovy in trouble?

    The competition among weight-loss drugs is heating up as Amgen (AMGN) reports positive early results from the development of its GLP-1 weight-loss drug, MariTide. The pharmaceutical company also topped first-quarter revenue estimates despite reporting a loss of $113 million. Yahoo Finance Senior Health Reporter Anjalee Khemlani breaks down how competition in the obesity drug market is ramping up as drug manufacturers find new medical use cases for this class of drugs. She refers back to comments made by Novo Nordisk (NVO) CEO Lars Fruergaard Jørgensen — Novo Nordisk makes Wegovy and Ozempic — and Eli Lilly (LLY) CEO Dave Ricks — Eli Lilly makes Zepbound and Mounjaro — to Yahoo Finance over the past several months. For more expert insight and the latest market action, click here to watch this full episode of Catalysts. This post was written by Melanie Riehl

  • Sony and Apollo confirm $26B proposed bid in Paramount talks

    Paramount Global (PARA) shares are flying higher in Friday morning's trading session — skyrocketing by nearly 14% in the last five trading days — after reports confirmed that Sony (SONY) and Apollo Global Management (APO) are pursuing an acquisition of the media giant. The proposed deal, valued at $26 billion in an all-cash bid, has Sony set to assume the role of the majority shareholder and Apollo taking a minority stake. Yahoo Finance Entertainment Reporter Alexandra Canal breaks down the details, providing insights into the state of Skydance Media's own talks with Paramount. Disclosure: Apollo Global Management is the parent company of Yahoo and Yahoo Finance. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Angel Smith

  • April jobs data, Apple earnings, Block and bitcoin: 3 Things

    US stock futures (^DJI, ^IXIC, ^GSPC) are ripping higher ahead of Friday's session open after the US Bureau of Labor Statistics reported 175,000 jobs were added to the US economy, a cooler print than previous months seen so far in 2024. What does this mean for interest rate cut hopes? Apple (AAPL) stock is rising in pre-market trading after topping fiscal second-quarter earnings estimates on Thursday, despite reporting falling iPhone sales year-over-year. Lastly, Block (SQ) shares are popping after reporting plans to focus more on bitcoin (BTC-USD) in its latest earnings report. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.

  • April jobs data: Industries that are hiring

    175,000 jobs were added to the US economy in April, according to the latest jobs data from the US Bureau of Labor Statistics, falling behind estimates of 240,000. Certain employment sectors saw significantly higher growth in nonfarm payroll jobs. Yahoo Finance's Alexandra Canal, Madison Mills, and Anjalee Khemlani break down hiring trends in three core industries: leisure and hospitality, manufacturing, and healthcare. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.

  • Leveraging AI successfully: Pinterest vs. Upstart

    Headline Venture Partner Kamran Ansari joins Market Domination for "Good Buy or Goodbye" to examine how using artificial intelligence can either make or break a stock. Ansari points to Pinterest (PINS) as a "good buy," as the social media site is building more tools for its users to discover new products and purchase them through partnerships with retail giants Amazon and Google. On the other hand, Ansari says "goodbye" to Upstart (UPST). He stresses that having artificial intelligence as a part of the financial technolog company's narrative is no longer a unique quality. Consumer lending also faces regulatory issues, where companies must ensure their AI models do not shift in prejudicial directions. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Melanie Riehl

  • Novo Nordisk slides while Moderna pops: Tale of two pharma stocks

    Pharmaceutical stocks Novo Nordisk (NVO) and Moderna (MRNA) are trending in opposite directions following their earnings reports. Despite topping Wall Street's profit expectations, Novo Nordisk shares are sinking as the company fell short of estimates for its popular GLP-1 weight-loss drug, Wegovy. Meanwhile, Moderna is on the rise even after reporting first quarter losses. Moderna's growth is largely due to an uptick in coronavirus boosters and an expansion into the Brazillian market. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Melanie Riehl

  • Moderna CEO on the changing COVID market: Pandemic to endemic

    Shares of pharmaceutical company Moderna (MRNA) are on the rise despite first quarter losses. Moderna CEO Stéphane Bancel tells Yahoo Finance Senior Reporter Anjalee Khemlani that the company is busy developing updated coronavirus vaccines for the 2024-2025 season and recently announced an expansion into the Brazilian market. As the coronavirus pandemic has shifted toward an endemic, Bancel explains how Moderna continues to innovate, sharing a positive outlook on phase two data for a combination flu and coronavirus vaccine. For more expert insight and the latest market action, click here to watch this full episode of Catalysts. This post was written by Melanie Riehl

  • Novo Nordisk CEO on weight-loss drugs' 'exciting growth story'

    Danish pharmaceutical company Novo Nordisk (NVO) topped first-quarter profit expectations, bringing in $9.5 billion in revenue over Wall Street estimates of $9.2 billion. However, the company fell short of sales estimates for its popular GLP-1 weight-loss drug, Wegovy. Novo Nordisk also manufactures the landmark weight-loss drug Ozempic. Novo Nordisk CEO Lars Fruergaard Jørgensen tells Yahoo Finance Senior Health Reporter Anjalee Khemlani that despite missing the mark on sales estimates, Wegovy has an "exciting growth story." The number of prescriptions has continued to rise across the United States, and more patients are seeing increased coverage as new health benefits and treatment use cases, like the decreased risk of cardiovascular disease, are uncovered. "We see a slight erosion in pricing that's not much different compared to what we have seen on other medicines. It's really about the significant volume opportunity that we are ramping manufacturing, we are getting more scripts, and we are helping many more patients deal with obesity," Jørgensen says on the pricing for these drugs. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Melanie Riehl

  • Fed holds rates, Apple earnings, Peloton CEO: 3 Things

    The Federal Reserve has elected to continue to hold rates steady, with Chair Jerome Powell echoing the decision suggesting rates will stay higher for longer in his press conference on Wednesday. Apple (AAPL) will report its fiscal second-quarter earnings after today's closing bell, with many eyes on Apple's performance in China after reported sluggishness in recent iPhone sales. Shares of Peloton (PTON) are moving higher in Thursday's pre-market session following reports of CEO Barry McCarthy's plans to step down. Yahoo Finance Reporters Jared Blikre, Dan Howley, and Madison Mills join the Morning Brief to break down the three things investors need to know ahead of May 2's market open. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Nicholas Jacobino

  • Shake Shack history: Beyond the Ticker

    Roadside burger chain Shake Shack (SHAK) may have just gone public in 2015, but it has been one of the fastest-growing fast-food chains for the past 20 years. In 2023, Shake Shack generated over $286 million in total revenue, up 20% year-over-year. Let's take a look at the company's biggest moments with Beyond the Ticker. 2001 It started as a hot dog cart, operated by restauranteur Danny Meyer in New York's Madison Square Park. 2004 That turned into a permanent location – where it added more menu items like burgers, fries, frozen custard, and those famous milkshakes. 2010 Meant to be a single location, there was an appetite for expansion. By 2010, two more locations were added in New York. One in the Upper West Side, and the second in the home to the New York Mets, Citi Field. 2015 On January 29, 2015, Shake Shack went public via initial public offering (IPO) on the New York Stock Exchange (NYSE) at $21 per share. 2017-2024 From there, the burger chain only continued to grow – expanding its digital platforms, partnering with third-party delivery service providers like Uber Eats (UBER), adding kiosks to stores, and even drive-thru's. 2024 This year at roughly 90 US locations, it’ll now be using Carbon Neutral Whole Milk, after it expanded its partnership with US-based carbon-neutral food company, Neutral Foods. In March, the company announced that CEO Randy Garutti would step down after a 20-year run. Rob Lynch, the current CEO of Papa John's, will be named the next CEO, effective May 20, 2024. And Shake Shack continues to make its mark on the fast-food, fast-casual industry, with 530 locations across the globe and growing. From tech giants to retail titans, Beyond the Ticker is a historical series that takes a deep dive into some of Wall Street's trending companies and how they transformed into the financial icons they are today. Check out more of our Beyond the Ticker series, and be sure to tune in to Yahoo Finance. Editor's note: This video was produced by Zach Faulds.

  • Fed decision, Amazon earnings, Starbucks sales: 3 Things

    US stocks (^DJI, ^IXIC, ^GSPC) saw their worst monthly performance of this year in April ahead of the Federal Reserve's next interest rate policy decision on Wednesday afternoon. The market is under pressure this morning as equities search for clarity in the Fed's messaging for future FOMC meetings. Amazon (AMZN) posted stellar first-quarter earnings results boosted by its AI and AWS cloud segments. Lastly, Starbucks (SBUX) stock tumbles in Wednesday pre-market trading after the coffee chain missed first-quarter earnings estimates and revealed declining same-store sales figures. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.

  • Eli Lilly stock jumps on weight-loss drug sales forecast

    Shares of Eli Lilly (LLY) are moving higher on Tuesday morning as the company reported its first-quarter earnings results, revealing a 26% year-over-year revenue increase in a figure of $8.77 billion. Ultimately, this revenue print fell short of estimates ($8.92 billion). The pharmaceutical giant did, however, raise its annual sales forecast by $2 billion due to an insatiable demand for its GLP-1 weight-loss drugs Mounjaro and Zepbound. Yahoo Finance Health Reporter Anjalee Khemlani joins Catalysts to break down the report and what it means for the company moving forward. For more expert insight and the latest market action, click here to watch this full episode of Catalysts. This post was written by Nicholas Jacobino

  • Paramount's CEO shakeup and what it signals for merger bids

    Paramount (PARA) CEO Bob Bakish will be stepping down and replaced by three chief executives from across Paramount's umbrella of TV networks in an “Office of the CEO” consortium. Yahoo Finance Entertainment Reporter Alexandra Canal explains the latest news on this shakeup and how it was addressed on Paramount's earnings call, and what this all means for looming merger bids from Skydance Media and a joint bid from Sony (SONY) and Apollo Global Management (APO). Disclosure: Apollo Global Management is the parent company of Yahoo and Yahoo Finance. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.

  • Amazon Q1 earnings: The 3 figures investors will be watching

    As the earnings season for Big Tech companies continues to captivate the markets, all eyes are now fixated on Amazon (AMZN), the tech giant poised to release its first-quarter results after the market's close on Tuesday. Yahoo Finance Senior Business Reporter Ines Ferré breaks down the top three things investors should watch for. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Angel Smith

  • Fed decision, Amazon earnings, McDonald's prices: 3 Things

    US equity markets (^DJI, ^IXIC, ^GSPC) face pressures ahead of the Federal Reserve's interest rate decision on Wednesday. Wall Street experts are expecting Fed officials to hold rates where they are coming out of their May FOMC meeting this week. Amazon (AMZN) will report its first-quarter earnings after Tuesday's market close, with many analysts eyeing the Magnificent Seven member's AI and cloud business segments. Lastly, McDonald's (MCD) shares fall in today's pre-market trading as higher menu prices drag down the fast-food chain's sales and revenue growth estimates. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.

  • Paramount CEO Bakish could be ousted as soon as Monday: Report

    Paramount Global CEO Bob Backish (PARA, PARAA) could be departing the company as soon as Monday, according to a report from The Wall Street Journal. Paramount has been engaged in exclusive merger talks with Skydance Media, but the exclusivity period is set to end on May 3. There are also reports that Apollo Global Management (APO), the parent company of Yahoo, and Sony (SONY) could team up to engage Paramount in deal discussions. The media giant is also set to release its first quarter results after the market close on Monday. Yahoo Finance's Alexandra Canal reports the latest news on the media giant. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Stephanie Mikulich.